Search

Bryan Y. Lee

Examiner (ID: 11209, Phone: (571)270-5606 , Office: P/2445 )

Most Active Art Unit
2445
Art Unit(s)
IWPI, 2445, 2615
Total Applications
446
Issued Applications
316
Pending Applications
28
Abandoned Applications
111

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5206834 [patent_doc_number] => 20070028316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Transgenic non-human Act1-deficient mammals and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/446450 [patent_app_country] => US [patent_app_date] => 2006-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 19928 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20070028316.pdf [firstpage_image] =>[orig_patent_app_number] => 11446450 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/446450
Transgenic non-human Act1-deficient mammals and uses thereof Jun 1, 2006 Abandoned
Array ( [id] => 5571624 [patent_doc_number] => 20090255003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Diagnostic and therapeutic target SLC39A11 proteins for neurodegenerative diseases' [patent_app_type] => utility [patent_app_number] => 11/920997 [patent_app_country] => US [patent_app_date] => 2006-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16662 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20090255003.pdf [firstpage_image] =>[orig_patent_app_number] => 11920997 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/920997
Diagnostic and therapeutic target SLC39A11 proteins for neurodegenerative diseases May 31, 2006 Abandoned
Array ( [id] => 5047777 [patent_doc_number] => 20070266451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Transgenic animals producing low-lactose milk and newly identified human small intestinal extracellular lactase-phlorizin hydrolase (ecLPH) gene' [patent_app_type] => utility [patent_app_number] => 11/434332 [patent_app_country] => US [patent_app_date] => 2006-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6343 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20070266451.pdf [firstpage_image] =>[orig_patent_app_number] => 11434332 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/434332
Transgenic animals producing low-lactose milk and newly identified human small intestinal extracellular lactase-phlorizin hydrolase (ecLPH) gene May 14, 2006 Issued
Array ( [id] => 5892338 [patent_doc_number] => 20060277617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Nucleic acid construct, metabolic disordered non-human animal and use thereof' [patent_app_type] => utility [patent_app_number] => 11/431891 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13660 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0277/20060277617.pdf [firstpage_image] =>[orig_patent_app_number] => 11431891 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/431891
Nucleic acid construct, metabolic disordered non-human animal and use thereof May 10, 2006 Issued
Array ( [id] => 5047778 [patent_doc_number] => 20070266452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'KSR2 knockout mice and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/431285 [patent_app_country] => US [patent_app_date] => 2006-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 5950 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20070266452.pdf [firstpage_image] =>[orig_patent_app_number] => 11431285 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/431285
KSR2 knockout mice and methods of use thereof May 9, 2006 Issued
Array ( [id] => 5644450 [patent_doc_number] => 20060282905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Animal models for demyelination disorders' [patent_app_type] => utility [patent_app_number] => 11/431372 [patent_app_country] => US [patent_app_date] => 2006-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 40454 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20060282905.pdf [firstpage_image] =>[orig_patent_app_number] => 11431372 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/431372
Animal models for demyelination disorders May 8, 2006 Issued
Array ( [id] => 5627266 [patent_doc_number] => 20060265771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Monitoring microrna expression and function' [patent_app_type] => utility [patent_app_number] => 11/412154 [patent_app_country] => US [patent_app_date] => 2006-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9980 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20060265771.pdf [firstpage_image] =>[orig_patent_app_number] => 11412154 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/412154
Monitoring microrna expression and function Apr 25, 2006 Abandoned
Array ( [id] => 5224671 [patent_doc_number] => 20070253937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Novel multipotent stem cells and use thereof' [patent_app_type] => utility [patent_app_number] => 11/412416 [patent_app_country] => US [patent_app_date] => 2006-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 17314 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20070253937.pdf [firstpage_image] =>[orig_patent_app_number] => 11412416 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/412416
Novel multipotent stem cells and use thereof Apr 25, 2006 Abandoned
Array ( [id] => 4933437 [patent_doc_number] => 20080004212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin' [patent_app_type] => utility [patent_app_number] => 11/408659 [patent_app_country] => US [patent_app_date] => 2006-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16444 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20080004212.pdf [firstpage_image] =>[orig_patent_app_number] => 11408659 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/408659
Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin Apr 20, 2006 Abandoned
Array ( [id] => 4983426 [patent_doc_number] => 20070087985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'MRCK-related compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/405735 [patent_app_country] => US [patent_app_date] => 2006-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11455 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20070087985.pdf [firstpage_image] =>[orig_patent_app_number] => 11405735 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/405735
MRCK-related compositions and methods Apr 17, 2006 Abandoned
Array ( [id] => 5690114 [patent_doc_number] => 20060288429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Genetic screen in drosophila for metastatic behavior' [patent_app_type] => utility [patent_app_number] => 11/399880 [patent_app_country] => US [patent_app_date] => 2006-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12287 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20060288429.pdf [firstpage_image] =>[orig_patent_app_number] => 11399880 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/399880
Genetic screen in drosophila for metastatic behavior Apr 6, 2006 Abandoned
Array ( [id] => 5626110 [patent_doc_number] => 20060264615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Cytokine polypeptides and nucleic acids' [patent_app_type] => utility [patent_app_number] => 11/398113 [patent_app_country] => US [patent_app_date] => 2006-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 58404 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264615.pdf [firstpage_image] =>[orig_patent_app_number] => 11398113 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/398113
Cytokine polypeptides and nucleic acids Apr 4, 2006 Abandoned
Array ( [id] => 5928555 [patent_doc_number] => 20060242724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Receptor' [patent_app_type] => utility [patent_app_number] => 11/385261 [patent_app_country] => US [patent_app_date] => 2006-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20811 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20060242724.pdf [firstpage_image] =>[orig_patent_app_number] => 11385261 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/385261
Receptor Mar 19, 2006 Abandoned
Array ( [id] => 81348 [patent_doc_number] => 07745214 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Methods of obtaining neural stem cells' [patent_app_type] => utility [patent_app_number] => 11/375889 [patent_app_country] => US [patent_app_date] => 2006-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 10 [patent_no_of_words] => 9624 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745214.pdf [firstpage_image] =>[orig_patent_app_number] => 11375889 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/375889
Methods of obtaining neural stem cells Mar 14, 2006 Issued
Array ( [id] => 5672072 [patent_doc_number] => 20060177426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Method of preserving lyophilized microorganisms for transport, storage and recovery of viable microorganisms' [patent_app_type] => utility [patent_app_number] => 11/347334 [patent_app_country] => US [patent_app_date] => 2006-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2190 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20060177426.pdf [firstpage_image] =>[orig_patent_app_number] => 11347334 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/347334
Method of preserving lyophilized microorganisms for transport, storage and recovery of viable microorganisms Feb 2, 2006 Abandoned
Array ( [id] => 4994138 [patent_doc_number] => 20070009483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Compositions and methods for the therapeutic treatment of diabetes' [patent_app_type] => utility [patent_app_number] => 11/347190 [patent_app_country] => US [patent_app_date] => 2006-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13701 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20070009483.pdf [firstpage_image] =>[orig_patent_app_number] => 11347190 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/347190
Compositions and methods for the therapeutic treatment of diabetes Feb 2, 2006 Abandoned
Array ( [id] => 5520950 [patent_doc_number] => 20090028931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Liposomal compositions for parenteral delivery of agents' [patent_app_type] => utility [patent_app_number] => 11/883255 [patent_app_country] => US [patent_app_date] => 2006-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13814 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20090028931.pdf [firstpage_image] =>[orig_patent_app_number] => 11883255 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/883255
Liposomal compositions for parenteral delivery of agents Jan 29, 2006 Abandoned
Array ( [id] => 5160426 [patent_doc_number] => 20070173470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Methods for delivering extracellular target into cells' [patent_app_type] => utility [patent_app_number] => 11/337109 [patent_app_country] => US [patent_app_date] => 2006-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6430 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20070173470.pdf [firstpage_image] =>[orig_patent_app_number] => 11337109 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/337109
Methods for delivering extracellular target into cells Jan 22, 2006 Abandoned
Array ( [id] => 5674151 [patent_doc_number] => 20060179506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'In vivo assay for neurite outgrowth in zebrafish and its application in drug screening' [patent_app_type] => utility [patent_app_number] => 11/327263 [patent_app_country] => US [patent_app_date] => 2006-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5996 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20060179506.pdf [firstpage_image] =>[orig_patent_app_number] => 11327263 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/327263
In vivo assay for neurite outgrowth in zebrafish and its application in drug screening Jan 5, 2006 Issued
Array ( [id] => 4758865 [patent_doc_number] => 20080311091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Engineered Dopamine Neurons and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/793797 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 24915 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311091.pdf [firstpage_image] =>[orig_patent_app_number] => 11793797 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/793797
Engineered Dopamine Neurons and Uses Thereof Dec 21, 2005 Abandoned
Menu